EMEA (Europe, Middle East and Africa) Statins Market Report 2017

August 2017 | 118 pages | ID: EBC178BD913EN
QYResearch

Abstracts

In this report, the EMEA Statins market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Statins for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Statins market competition by top manufacturers/players, with Statins sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Merck
• Teva
• Amgen
• Abbott
• AstraZeneca
• Novartis
• SUN Pharma
• Torrent Pharmaceuticals
• GlaxoSmithKline
• HanAll BioPharma
• JX Pharmaceuticals
• Aurobindo Pharma
• Abbvie
• Cerenis Therapeutics

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Atorvastatin (Lipitor)
• Fluvastatin (Lescol)
• Lovastatin
• Pitavastatin (Livalo)
• Pravastatin (Pravachol)
• Rosuvastatin (Crestor)
• Simvastatin (Zocor)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Statins for each application, including

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Statins Market Report 2017

1 STATINS OVERVIEW

1.1 Product Overview and Scope of Statins
1.2 Classification of Statins
  1.2.1 EMEA Statins Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Statins Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Atorvastatin (Lipitor)
  1.2.4 Fluvastatin (Lescol)
  1.2.5 Lovastatin
  1.2.6 Pitavastatin (Livalo)
  1.2.7 Pravastatin (Pravachol)
  1.2.8 Rosuvastatin (Crestor)
  1.2.9 Simvastatin (Zocor)
1.3 EMEA Statins Market by Application/End Users
  1.3.1 EMEA Statins Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacy
  1.3.4 Online Pharmacy
1.4 EMEA Statins Market by Region
  1.4.1 EMEA Statins Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Statins (2012-2022)
  1.5.1 EMEA Statins Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Statins Revenue and Growth Rate (2012-2022)

2 EMEA STATINS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Statins Market Competition by Players/Manufacturers
  2.1.1 EMEA Statins Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Statins Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Statins Sale Price by Players (2012-2017)
2.2 EMEA Statins (Volume and Value) by Type/Product Category
  2.2.1 EMEA Statins Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Statins Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Statins Sale Price by Type (2012-2017)
2.3 EMEA Statins (Volume) by Application
2.4 EMEA Statins (Volume and Value) by Region
  2.4.1 EMEA Statins Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Statins Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Statins Sales Price by Region (2012-2017)

3 EUROPE STATINS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Statins Sales and Value (2012-2017)
  3.1.1 Europe Statins Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Statins Revenue and Growth Rate (2012-2017)
3.2 Europe Statins Sales and Market Share by Type
3.3 Europe Statins Sales and Market Share by Application
3.4 Europe Statins Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Statins Sales Volume by Countries (2012-2017)
  3.4.2 Europe Statins Revenue by Countries (2012-2017)
  3.4.3 Germany Statins Sales and Growth Rate (2012-2017)
  3.4.4 France Statins Sales and Growth Rate (2012-2017)
  3.4.5 UK Statins Sales and Growth Rate (2012-2017)
  3.4.6 Russia Statins Sales and Growth Rate (2012-2017)
  3.4.7 Italy Statins Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Statins Sales and Growth Rate (2012-2017)

4 MIDDLE EAST STATINS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Statins Sales and Value (2012-2017)
  4.1.1 Middle East Statins Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Statins Revenue and Growth Rate (2012-2017)
4.2 Middle East Statins Sales and Market Share by Type
4.3 Middle East Statins Sales and Market Share by Application
4.4 Middle East Statins Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Statins Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Statins Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Statins Sales and Growth Rate (2012-2017)
  4.4.4 Israel Statins Sales and Growth Rate (2012-2017)
  4.4.5 UAE Statins Sales and Growth Rate (2012-2017)
  4.4.6 Iran Statins Sales and Growth Rate (2012-2017)

5 AFRICA STATINS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Statins Sales and Value (2012-2017)
  5.1.1 Africa Statins Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Statins Revenue and Growth Rate (2012-2017)
5.2 Africa Statins Sales and Market Share by Type
5.3 Africa Statins Sales and Market Share by Application
5.4 Africa Statins Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Statins Sales Volume by Countries (2012-2017)
  5.4.2 Africa Statins Revenue by Countries (2012-2017)
  5.4.3 South Africa Statins Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Statins Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Statins Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Statins Sales and Growth Rate (2012-2017)

6 EMEA STATINS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Statins Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Statins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Statins Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Statins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Teva
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Statins Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Teva Statins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Amgen
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Statins Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Amgen Statins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Abbott
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Statins Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Abbott Statins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AstraZeneca
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Statins Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AstraZeneca Statins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novartis
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Statins Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novartis Statins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 SUN Pharma
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Statins Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 SUN Pharma Statins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Torrent Pharmaceuticals
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Statins Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Torrent Pharmaceuticals Statins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 GlaxoSmithKline
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Statins Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 GlaxoSmithKline Statins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 HanAll BioPharma
6.12 JX Pharmaceuticals
6.13 Aurobindo Pharma
6.14 Abbvie
6.15 Cerenis Therapeutics

7 STATINS MANUFACTURING COST ANALYSIS

7.1 Statins Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Statins

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Statins Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Statins Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA STATINS MARKET FORECAST (2017-2022)

11.1 EMEA Statins Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Statins Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Statins Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Statins Price and Trend Forecast (2017-2022)
11.2 EMEA Statins Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Statins Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Statins Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Statins Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Statins Sales Forecast by Type (2017-2022)
11.7 EMEA Statins Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Statins
Figure EMEA Statins Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Statins Sales Volume Market Share by Type (Product Category) in 2016
Figure Atorvastatin (Lipitor) Product Picture
Figure Fluvastatin (Lescol) Product Picture
Figure Lovastatin Product Picture
Figure Pitavastatin (Livalo) Product Picture
Figure Pravastatin (Pravachol) Product Picture
Figure Rosuvastatin (Crestor) Product Picture
Figure Simvastatin (Zocor) Product Picture
Figure EMEA Statins Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Statins by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure EMEA Statins Market Size (Million USD) by Region (2012-2022)
Figure Europe Statins Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Statins Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Statins Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Statins Revenue (Million USD) Status and Forecast by Countries
Figure Africa Statins Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Statins Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Statins Sales Volume and Growth Rate (2012-2022)
Figure EMEA Statins Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Statins Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Statins Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Statins Sales Share by Players (2012-2017)
Figure 2016 Statins Sales Share by Players
Figure 2017 Statins Sales Share by Players
Figure EMEA Statins Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Statins Revenue (Million USD) by Players (2012-2017)
Table EMEA Statins Revenue Share by Players (2012-2017)
Table 2016 EMEA Statins Revenue Share by Players
Table 2017 EMEA Statins Revenue Share by Players
Table EMEA Statins Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Statins Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Statins Sales Share by Type (2012-2017)
Figure Sales Market Share of Statins by Type (2012-2017)
Figure EMEA Statins Sales Market Share by Type (2012-2017)
Table EMEA Statins Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Statins Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Statins by Type in 2016
Table EMEA Statins Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Statins Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Statins Sales Share by Application (2012-2017)
Figure Sales Market Share of Statins by Application (2012-2017)
Figure EMEA Statins Sales Market Share by Application in 2016
Table EMEA Statins Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Statins Sales Share by Region (2012-2017)
Figure Sales Market Share of Statins by Region (2012-2017)
Figure EMEA Statins Sales Market Share in 2016
Table EMEA Statins Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Statins Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Statins by Region (2012-2017)
Figure EMEA Statins Revenue Market Share Regions in 2016
Table EMEA Statins Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Statins Revenue and Growth Rate (2012-2017)
Table Europe Statins Sales (K Units) by Type (2012-2017)
Table Europe Statins Market Share by Type (2012-2017)
Figure Europe Statins Market Share by Type in 2016
Table Europe Statins Sales (K Units) by Application (2012-2017)
Table Europe Statins Market Share by Application (2012-2017)
Figure Europe Statins Market Share by Application in 2016
Table Europe Statins Sales (K Units) by Countries (2012-2017)
Table Europe Statins Sales Market Share by Countries (2012-2017)
Figure Europe Statins Sales Market Share by Countries (2012-2017)
Figure Europe Statins Sales Market Share by Countries in 2016
Table Europe Statins Revenue (Million USD) by Countries (2012-2017)
Table Europe Statins Revenue Market Share by Countries (2012-2017)
Figure Europe Statins Revenue Market Share by Countries (2012-2017)
Figure Europe Statins Revenue Market Share by Countries in 2016
Figure Germany Statins Sales (K Units) and Growth Rate (2012-2017)
Figure France Statins Sales (K Units) and Growth Rate (2012-2017)
Figure UK Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Statins Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Statins Sales (K Units) by Type (2012-2017)
Table Middle East Statins Market Share by Type (2012-2017)
Figure Middle East Statins Market Share by Type (2012-2017)
Table Middle East Statins Sales (K Units) by Applications (2012-2017)
Table Middle East Statins Market Share by Applications (2012-2017)
Figure Middle East Statins Sales Market Share by Application in 2016
Table Middle East Statins Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Statins Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Statins Sales Volume Market Share by Countries in 2016
Table Middle East Statins Revenue (Million USD) by Countries (2012-2017)
Table Middle East Statins Revenue Market Share by Countries (2012-2017)
Figure Middle East Statins Revenue Market Share by Countries (2012-2017)
Figure Middle East Statins Revenue Market Share by Countries in 2016
Figure Saudi Arabia Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Statins Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Statins Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Statins Sales (K Units) by Type (2012-2017)
Table Africa Statins Sales Market Share by Type (2012-2017)
Figure Africa Statins Sales Market Share by Type (2012-2017)
Figure Africa Statins Sales Market Share by Type in 2016
Table Africa Statins Sales (K Units) by Application (2012-2017)
Table Africa Statins Sales Market Share by Application (2012-2017)
Figure Africa Statins Sales Market Share by Application (2012-2017)
Table Africa Statins Sales Volume (K Units) by Countries (2012-2017)
Table Africa Statins Sales Market Share by Countries (2012-2017)
Figure Africa Statins Sales Market Share by Countries (2012-2017)
Figure Africa Statins Sales Market Share by Countries in 2016
Table Africa Statins Revenue (Million USD) by Countries (2012-2017)
Table Africa Statins Revenue Market Share by Countries (2012-2017)
Figure Africa Statins Revenue Market Share by Countries (2012-2017)
Figure Africa Statins Revenue Market Share by Countries in 2016
Figure South Africa Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Statins Sales (K Units) and Growth Rate (2012-2017)
Table Pfizer Statins Basic Information List
Table Pfizer Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Statins Sales Market Share in EMEA (2012-2017)
Figure Pfizer Statins Revenue Market Share in EMEA (2012-2017)
Table Merck Statins Basic Information List
Table Merck Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Statins Sales Market Share in EMEA (2012-2017)
Figure Merck Statins Revenue Market Share in EMEA (2012-2017)
Table Teva Statins Basic Information List
Table Teva Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Teva Statins Sales Market Share in EMEA (2012-2017)
Figure Teva Statins Revenue Market Share in EMEA (2012-2017)
Table Amgen Statins Basic Information List
Table Amgen Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Statins Sales Market Share in EMEA (2012-2017)
Figure Amgen Statins Revenue Market Share in EMEA (2012-2017)
Table Abbott Statins Basic Information List
Table Abbott Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Statins Sales Market Share in EMEA (2012-2017)
Figure Abbott Statins Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Statins Basic Information List
Table AstraZeneca Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Statins Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Statins Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Statins Revenue Market Share in EMEA (2012-2017)
Table Novartis Statins Basic Information List
Table Novartis Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Statins Sales Market Share in EMEA (2012-2017)
Figure Novartis Statins Revenue Market Share in EMEA (2012-2017)
Table SUN Pharma Statins Basic Information List
Table SUN Pharma Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure SUN Pharma Statins Sales (K Units) and Growth Rate (2012-2017)
Figure SUN Pharma Statins Sales Market Share in EMEA (2012-2017)
Figure SUN Pharma Statins Revenue Market Share in EMEA (2012-2017)
Table Torrent Pharmaceuticals Statins Basic Information List
Table Torrent Pharmaceuticals Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Torrent Pharmaceuticals Statins Sales (K Units) and Growth Rate (2012-2017)
Figure Torrent Pharmaceuticals Statins Sales Market Share in EMEA (2012-2017)
Figure Torrent Pharmaceuticals Statins Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Statins Basic Information List
Table GlaxoSmithKline Statins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Statins Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Statins Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Statins Revenue Market Share in EMEA (2012-2017)
Table HanAll BioPharma Statins Basic Information List
Table JX Pharmaceuticals Statins Basic Information List
Table Aurobindo Pharma Statins Basic Information List
Table Abbvie Statins Basic Information List
Table Cerenis Therapeutics Statins Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Statins
Figure Manufacturing Process Analysis of Statins
Figure Statins Industrial Chain Analysis
Table Raw Materials Sources of Statins Major Manufacturers in 2016
Table Major Buyers of Statins
Table Distributors/Traders List
Figure EMEA Statins Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Statins Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Statins Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Statins Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Statins Sales Market Share Forecast by Region (2017-2022)
Table EMEA Statins Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Statins Revenue Market Share Forecast by Region (2017-2022)
Table Europe Statins Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Statins Sales Market Share Forecast by Countries (2017-2022)
Table Europe Statins Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Statins Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Statins Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Statins Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Statins Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Statins Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Statins Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Statins Sales Market Share Forecast by Countries (2017-2022)
Table Africa Statins Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Statins Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Statins Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Statins Sales Market Share Forecast by Type (2017-2022)
Table EMEA Statins Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Statins Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources